Back to search

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

Data up to Jan 2025

Published2009
Citations1,049
References80

Total Citations Per Year

Abstract

References (80)

“Mini-mental state”

1975 • 82,784 citations

Clinical diagnosis of Alzheimer's disease

1984 • 27,279 citations

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

2002 • 15,303 citations

Neuropathological stageing of Alzheimer-related changes

1991 • 14,533 citations

Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

2003 • 8,902 citations

The Clinical Dementia Rating (CDR)

1993 • 8,861 citations

What's wrong with Bonferroni adjustments

1998 • 5,540 citations

A nonparametric method for automatic correction of intensity nonuniformity in MRI data

1998 • 4,609 citations

Current Concepts in Mild Cognitive Impairment

2001 • 4,609 citations

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

2004 • 4,223 citations

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1991 • 4,120 citations

The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods

2008 • 3,825 citations

DSM-IV: Diagnostic and Statistical Manual of Mental Disorders

1994 • 2,484 citations

Mixed brain pathologies account for most dementia cases in community-dwelling older persons

2007 • 1,695 citations

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

2006 • 1,661 citations

Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data

2005 • 1,225 citations

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans

2005 • 1,216 citations

Imaging β-amyloid burden in aging and dementia

2007 • 1,037 citations

[ 11 C]PIB in a nondemented population

2006 • 1,030 citations

Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly

2008 • 1,004 citations

Synthesis and Evaluation of 11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents

2003 • 953 citations

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

2008 • 929 citations

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

2008 • 903 citations

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD

2000 • 898 citations

Cerebrospinal Fluid tau/β-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults

2007 • 869 citations

MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease

1992 • 848 citations

-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

2007 • 792 citations

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

2004 • 791 citations

PET imaging of amyloid deposition in patients with mild cognitive impairment

2007 • 701 citations

Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects

2008 • 644 citations

Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease

1999 • 631 citations

Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain

2004 • 617 citations

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease

2006 • 605 citations

Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults.

1989 • 592 citations

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

2002 • 574 citations

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.

2005 • 524 citations

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions

2005 • 517 citations

Amyloid, hypometabolism, and cognition in Alzheimer disease

2006 • 506 citations

Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI

2005 • 482 citations

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy

2007 • 478 citations

Imaging amyloid deposition in Lewy body diseases

2008 • 440 citations

PET imaging of amyloid in Alzheimer's disease

2004 • 438 citations

The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease

1999 • 427 citations

Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical Dementia

2006 • 385 citations

The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI

1997 • 380 citations

11 C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration

2007 • 363 citations

Using Serial Registered Brain Magnetic Resonance Imaging to Measure Disease Progression in Alzheimer Disease

2000 • 353 citations

Cerebrospinal Fluid Tau and β-Amyloid

2003 • 350 citations

Hippocampal volume as an index of Alzheimer neuropathology

2002 • 343 citations

Molecular Imaging With Pittsburgh Compound B Confirmed at Autopsy

2007 • 343 citations

MRI correlates of neurofibrillary tangle pathology at autopsy

2008 • 331 citations

PET amyloid ligand [ 11 C]PIB uptake is increased in mild cognitive impairment

2007 • 320 citations

The Short Test of Mental Status

1991 • 318 citations

Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study

2006 • 315 citations

PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis

2007 • 301 citations

Neuropathological basis of magnetic resonance images in aging and dementia

2007 • 295 citations

Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease

2008 • 288 citations

Changes in premorbid brain volume predict Alzheimer’s disease pathology

2003 • 275 citations

Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease

2008 • 271 citations

Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment

2005 • 257 citations

Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia

2005 • 236 citations

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s disease

2007 • 208 citations

Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study

2003 • 206 citations

Assessment of β-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography With Carbon 11–Labeled Pittsburgh Compound B

2008 • 205 citations

Comparison of the Short Test of Mental Status and the Mini-Mental State Examination in Mild Cognitive Impairment

2003 • 198 citations

Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C‐PIB positron emission tomography study

2006 • 180 citations

Atrophy rates accelerate in amnestic mild cognitive impairment

2007 • 169 citations

Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage

2008 • 167 citations

Rates of cerebral atrophy differ in different degenerative pathologies

2006 • 163 citations

The Appropriateness of Analysis of Variance and Multiple-Comparison Procedures

1983 • 151 citations

Core biological marker candidates of Alzheimer?s disease ? perspectives for diagnosis, prediction of outcome and reflection of biological activity

2004 • 129 citations

Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects.

2004 • 119 citations

Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients

2003 • 113 citations

No association of CSF biomarkers with APOE 4, plaque and tangle burden in definite Alzheimer's disease

2007 • 112 citations

Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: A longitudinal study

2008 • 103 citations

Methodological considerations for measuring rates of brain atrophy

2003 • 90 citations

Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B

2008 • 77 citations

Longitudinal Cerebral Blood Flow and Amyloid Deposition: An Emerging Pattern?

2008 • 67 citations

P1‐288: Automated ROI analysis of 11C Pittsburgh compound B images using structural magnetic resonance imaging atlases

2008 • 3 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...